Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hilberg

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncogene|December 1, 1992
Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicityF Hilberg, E F Wagner
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsetsU Protin, T Schweighoffer, W Jochum, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cellsM Grez, E Akgün, F Hilberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cellsF Hilberg, C Stocking, W Ostertag, et al.
Nature|September 9, 1993
c-jun is essential for normal mouse development and hepatogenesisF Hilberg, A Aguzzi, N Howells, et al.
Molecular and Cellular Biology|November 1, 1985
Cloning of hexokinase structural genes from Saccharomyces cerevisiae mutants with regulatory mutations responsible for glucose repressionK D Entian, F Hilberg, H Opitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1986
Retroviral mutants efficiently expressed in embryonal carcinoma cellsT Franz, F Hilberg, B Seliger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinomaM Krause, F Hessel, D Zips, et al.
British Journal of Cancer|September 13, 2017
Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patientsM Gabasa, R Ikemori, F Hilberg, et al.
Cell Adhesion and Communication|November 21, 1998
How tumor cells make use of CD44P Herrlich, J Sleeman, D Wainwright, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncogene|December 1, 1992
Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicityF Hilberg, E F Wagner
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsetsU Protin, T Schweighoffer, W Jochum, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cellsM Grez, E Akgün, F Hilberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cellsF Hilberg, C Stocking, W Ostertag, et al.
Nature|September 9, 1993
c-jun is essential for normal mouse development and hepatogenesisF Hilberg, A Aguzzi, N Howells, et al.
Molecular and Cellular Biology|November 1, 1985
Cloning of hexokinase structural genes from Saccharomyces cerevisiae mutants with regulatory mutations responsible for glucose repressionK D Entian, F Hilberg, H Opitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1986
Retroviral mutants efficiently expressed in embryonal carcinoma cellsT Franz, F Hilberg, B Seliger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinomaM Krause, F Hessel, D Zips, et al.
British Journal of Cancer|September 13, 2017
Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patientsM Gabasa, R Ikemori, F Hilberg, et al.
Cell Adhesion and Communication|November 21, 1998
How tumor cells make use of CD44P Herrlich, J Sleeman, D Wainwright, et al.
Pageof 2